Skoda has unveiled a fresh all-electric SUV, the Elroq, that will replace the Karoq overseas in the near future. This new SUV will be Skoda's second born EV that will be followed by four more electric cars globally by 2026.
- Skoda Elroq will sit below the Enyaq
- Will rival Jeep Avenger overseas
- Four more Skoda born EVs to follow Elroq
Skoda Elroq: first SUV to get Modern Solid design language
Skoda's all-new and rugged design language Modern Solid will be seen on the Elroq, which will be the first SUV to get this styling theme. It includes a more rugged front end (named Tech Deck), large skidplates front and rear, as well as swollen, squared-off arches and a raised 4x4-esque profile.
The Elroq will give Skoda a footing in the hugely competitive – and growing – electric compact SUV segment, competing with rivals, including the Jeep Avenger, Mini Aceman and Ford Explorer EV that was shown recently.
Skoda Elroq: expected powertrain
The Elroq will likely be offered with a 77kWh battery for a range of around 480km in its most efficient guise – similar to its Skoda Enyaq iV sibling, with which it will share the majority of its parts. Skoda will also launch a new 86kWh battery in its EVs next year, beginning with the Enyaq, which could also make its way into the Elroq to give a range of more than 595km.
Like the Enyaq, the MEB-based SUV is expected to be offered with several power outputs, with the most powerful – that could gain the vRS nameplate – potentially bringing a dual-motor set-up with around 300hp. Though, notably, the Karoq it replaces has only ever been two-wheel drive.
Following the Elroq in Skoda’s new-look EV offering, there will be a £22,000 entry-level compact urban crossover in 2025, and in 2026, an Octavia-sized electric estate and a production version of the Vision 7S MPV concept. Facelifts of the Enyaq iV SUV and coupe have also been confirmed for 2024.
Also see:
Skoda Karoq review, test drive
‘India key to Skoda’s internationalisation plans’: CEO Klaus Zellmer
Comments
Member Login
Personal Details
No comments yet. Be the first to comment.